European stocks rallied on Monday boosted by hopes of a COVID-19 treatment after Eli Lilly said it was beginning a phase 3 trial of its experimental drug to see whether it can prevent the virus' spread in residents and staff in US nursing homes. Earlier, gains were supported by better-than-expected PMI data for the Eurozone, in particular Italy and Spain, two of the most affected countries by the pandemic. Still, investors remain concerned over surging coronavirus infections and the escalation of tensions between US and China as Washington is set to announce new actions related to Chinese software companies in the coming days. Meantime, US lawmakers are still debating a coronavirus-relief package. On the corporate side, HSBC and Societe Generale fell due to weak quarterly reports.
Historically, the Germany DAX 30 Stock Market Index reached an all time high of 13797.12 in February of 2020. Germany DAX 30 Stock Market Index - data, forecasts, historical chart - was last updated on August of 2020.
The Germany DAX 30 Stock Market Index is expected to trade at 12098.45 points by the end of this quarter, according to Trading Economics global macro models and analysts expectations. Looking forward, we estimate it to trade at 11268.43 in 12 months time.